PharmaSci
ActiveSummary
PharmaSci has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €843,807 and a net result of €61,401. Equity is growing by ~18.1% per year across the filed fiscal years. Its solvency ranks better than 47% of 8782 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability47▼-8
Solvency75▲+3
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55,000 at 30 days acceptable
Liquidity short (current ratio 0.13 against 0.07 in 2024; short-term debt: 22.9% and cash: 0% of total assets), and 50.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Activities of head offices; management consultancy activities (NACE 70)
about 69% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
49.6%
Return on assets
3.6%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-08-2026, 21 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
21 d late
2024
29 d late
2023
26 d early
2022
24 d early
2021
75 d early
2020
3 d early
2019
87 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 24 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€843,807▲ 7.8%
2024 · €782,406
Total assets
€1.7m▲ 1.4%
2024 · €1.7m
Net result
€61,401▼ 47.1%
2024 · €116,038
Working capital
-€341,235▼ 9.4%
2024 · -€311,852
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€144,537▲ 10.8%€140,919▼ 2.5%€163,501▲ 16.0%€171,945▲ 5.2%€92,106▼ 46.4%
Net result€92,159within the sector's middle half▲ 11.9%€93,732within the sector's middle half▲ 1.7%€112,067within the sector's middle half▲ 19.6%€116,038within the sector's middle half▲ 3.5%€61,401within the sector's middle half▼ 47.1%
Equity€448,169within the sector's middle half▲ 25.9%€541,901within the sector's middle half▲ 20.9%€666,368within the sector's middle half▲ 23.0%€782,406within the sector's middle half▲ 17.4%€843,807within the sector's middle half▲ 7.8%
Total assets€1.7mwithin the sector's middle half=€1.7mwithin the sector's middle half▼ 0.7%€1.7mwithin the sector's middle half▲ 0.5%€1.7mwithin the sector's middle half=€1.7mwithin the sector's middle half▲ 1.4%
Debt€1.2m▼ 6.9%€1.1m▼ 8.5%€1.0m▼ 10.3%€896,316▼ 11.5%€858,781▼ 4.2%
Working capital-€321,329below the sector's middle half▼ 56.4%-€335,669below the sector's middle half▼ 4.5%-€310,026below the sector's middle half▲ 7.6%-€311,852below the sector's middle half▼ 0.6%-€341,235below the sector's middle half▼ 9.4%
Solvency26.6%within the sector's middle half▲ 5.5pp32.4%within the sector's middle half▲ 5.8pp39.7%within the sector's middle half▲ 7.3pp46.6%within the sector's middle half▲ 6.9pp49.6%within the sector's middle half▲ 3.0pp
Current ratio0.08below the sector's middle half▼ 0.040.05below the sector's middle half▼ 0.030.08below the sector's middle half▲ 0.030.07below the sector's middle half=0.13below the sector's middle half▲ 0.05
Return on assets (ROA)5.5%within the sector's middle half▲ 0.6pp5.6%within the sector's middle half▲ 0.1pp6.7%within the sector's middle half▲ 1.1pp6.9%within the sector's middle half▲ 0.2pp3.6%within the sector's middle half▼ 3.3pp
above
within
below
the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 46% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.7m
Fixed assets
€1.7m =
Current assets
€48,854 ▲ 95.5%
Equity and liabilities €1.7m
Equity
€843,807 ▲ 7.8%
Debt
€858,781 ▼ 4.2%
Debt's share of the balance-sheet total falls from 53.4% to 50.4%. Equity is higher and debt is lower.
Key figures and ratios
Debt to equity
1.02▼
2024 · 1.15
ROE
7.3%▼
2024 · 14.8%
Debt ≤ 1 year
€390,089▲
2024 · €336,840
Debt > 1 year
€465,467▼
2024 · €556,007
Income taxes
€18,798▼
2024 · €37,314
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | €930 | €1,138 | €1,653 | €1,990 | ▲ 20.4% |
| Gross operating margin9900 | €146,701 | €141,849 | €164,639 | €173,598 | €94,096 | ▼ 45.8% |
| Operating profit (loss)9901 | €144,537 | €140,919 | €163,501 | €171,945 | €92,106 | ▼ 46.4% |
| Financial income75/76B | - | €702 | €913 | €1,855 | €1,798 | ▼ 3.1% |
| Recurring financial income75 | €881 | €702 | €913 | €1,855 | €1,798 | ▼ 3.1% |
| Financial charges65/66B | - | €19,694 | €17,551 | €20,448 | €13,704 | ▼ 33.0% |
| Recurring financial charges65 | €24,282 | €19,694 | €17,551 | €20,448 | €13,704 | ▼ 33.0% |
| Profit (loss) for the period before taxes9903 | €121,136 | €121,926 | €146,863 | €153,352 | €80,200 | ▼ 47.7% |
| Income taxes67/77 | €28,977 | €28,195 | €34,796 | €37,314 | €18,798 | ▼ 49.6% |
| Profit (loss) for the period9904 | €92,159 | €93,732 | €112,067 | €116,038 | €61,401 | ▼ 47.1% |
| Profit (loss) for the period to be appropriated9905 | €92,159 | €93,732 | €112,067 | €116,038 | €61,401 | ▼ 47.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.7m | €1.7m | €1.7m | €1.7m | €1.7m | ▲ 1.4% |
| Fixed assets21/28 | €1.7m | €1.7m | €1.7m | €1.7m | €1.7m | = |
| Financial fixed assets28 | €1.7m | €1.7m | €1.7m | €1.7m | €1.7m | = |
| Current assets29/58 | €29,120 | €17,335 | €25,314 | €24,988 | €48,854 | ▲ 95.5% |
| Amounts receivable within one year40/41 | €11,770 | €10,969 | €16,629 | €22,137 | €45,853 | ▲ 107% |
| Other amounts receivable41 | - | €10,969 | €16,629 | €22,137 | €45,853 | ▲ 107% |
| Cash at bank and in hand54/58 | €10,039 | €6,099 | €8,410 | €0 | €146 | - |
| Deferred charges and accrued income490/1 | - | €268 | €276 | €2,851 | €2,855 | ▲ 0.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.7m | €1.7m | €1.7m | €1.7m | €1.7m | ▲ 1.4% |
| Equity10/15 | €448,169 | €541,901 | €666,368 | €782,406 | €843,807 | ▲ 7.8% |
| Contributions10/11 | - | €6,200 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €441,969 | €535,701 | €647,768 | €763,806 | €825,207 | ▲ 8.0% |
| Non-distributable reserves130/1 | - | €1,855 | €1,855 | €0 | - | - |
| Reserves not available under the articles1311 | - | €1,855 | €1,855 | €0 | - | - |
| Distributable reserves133 | - | €533,846 | €645,913 | €763,806 | €825,207 | ▲ 8.0% |
| Profit (loss) carried forward14 | €265,591 | - | - | - | - | - |
| Amounts payable17/49 | €1.2m | €1.1m | €1.0m | €896,316 | €858,781 | ▼ 4.2% |
| Amounts payable after more than one year17 | €881,347 | €772,638 | €675,454 | €556,007 | €465,467 | ▼ 16.3% |
| Financial debts170/4 | - | €772,638 | €675,454 | €556,007 | €465,467 | ▼ 16.3% |
| Amounts payable within one year42/48 | €350,449 | €353,005 | €335,340 | €336,840 | €390,089 | ▲ 15.8% |
| Current portion of amounts payable after more than one year42 | - | €108,709 | €110,791 | €95,739 | €90,539 | ▼ 5.4% |
| Financial debts43 | - | - | - | €14,037 | €0 | ▼ 100% |
| Credit institutions430/8 | - | - | - | €14,037 | €0 | ▼ 100% |
| Trade debts44 | €2,639 | €679 | €2,495 | €4,898 | €996 | ▼ 79.7% |
| Suppliers440/4 | - | €679 | €2,495 | €4,898 | €996 | ▼ 79.7% |
| Taxes, remuneration and social security45 | - | €31,013 | €38,856 | €39,203 | €58,008 | ▲ 48.0% |
| Taxes450/3 | - | €31,013 | €36,752 | €39,203 | €58,008 | ▲ 48.0% |
| Remuneration and social security454/9 | - | - | €2,103 | €0 | - | - |
| Other amounts payable47/48 | - | €212,604 | €183,200 | €182,964 | €240,546 | ▲ 31.5% |
| Accrued charges and deferred income492/3 | - | €3,526 | €1,886 | €3,469 | €3,225 | ▼ 7.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €92,159 | €93,732 | €112,067 | €116,038 | €61,401 | ▼ 47.1% |
| Operating cash flow (approximation) | €92,159 | €93,732 | €112,067 | €116,038 | €61,401 | ▼ 47.1% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | -€3,940 | €2,311 | -€8,410 | €146 | ▲ 102% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
21-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 21 days late
2025
31-12
Financial
Weakest financial yearnet €61,401 ▼47.1%
Net result drops to €61,401, the lowest in the series.
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 29 days late
2024
31-12
Financial
Highest result since 2019net €116,038 ▲3.5%
Operating result €171,945, net result €116,038, both a record.
04-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
06-04
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
Financial
Equity above €500,000Eq €541,901 ▲20.9%
4 profitable years in a row build equity to €541,901.
14-02
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
27-04
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
03-02
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
22-02
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
29-03
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
17-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 3 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Rotselaar · 1 establishment unit since 2015
Ground area
1,140 m²
Building footprint
467 m²
Volume, LiDAR
2,969 m³
2 parcels, Flanders · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
4
companies at this address
See who is registered here
1 establishment unit
PharmaSci
since 20152.246.928.883
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24094D0492/00S002 | Flanders | 650 m² | 1 · 127 m² | 7.8 m · 2 fl. |
| 24094B0980/00K000 | Flanders | 490 m² | 1 · 339 m² | 10.6 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 1
-
100%
According to the 2025 annual accounts of PharmaSci and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
TEAMTRAC
BE 0864.889.711
Asse · Eq €843,805
VV Mobilis
BE 0640.921.362
Nivelles · Eq €843,815
CONSEBT
BE 0810.718.773
Zedelgem · Eq €843,642
CONSIS
BE 0470.657.856
Maarkedal · Eq €843,533
MICHAËL DEMEYER
BE 0771.525.726
Aalter · Eq €844,425
Of 82,601 companies in this sector we hold annual accounts for 52,629. 29,716 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded11-09-2015
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
86995Nutrition and dietetics services
E-invoicing
Reachable via Peppol
Peppol ID
0208:0636973759
Also
9925:BE0636973759
Registered
18-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.